Progress in Neurotherapeutics and Neuropsychopharmacology

As this article doesn't contain an abstract, the image below is necessary to enable the article to be indexed by certain search engines. The resolution of the full-text PDF is much higher than that shown here.


Review Article

Radiotherapy with Concurrent and Adjuvant Temozolomide: A New Standard of Care for Glioblastoma Multiforme


Warren P. Mason a1c1, René O. Mirimanoff a2 and Roger Stupp a3
a1 Department of Medicine, Princess Margaret Hospital and the University of Toronto, Toronto, Canada; Email: Warren.Mason@uhn.on.ca
a2 Department of Radiation Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Email: Rene_Olivier.Mirimanoff@chuv.ch
a3 Multidisciplinary Oncology Center, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Email: Roger.Stupp@chuv.ch

Article author query
mason wp   [PubMed][Google Scholar] 
mirimanoff ro   [PubMed][Google Scholar] 
stupp r   [PubMed][Google Scholar] 

Key Words: temozolomide; glioblastoma; clinical trial; neurotherapeutics; radiotherapy; quality of life.

Correspondence:
c1 Correspondence should be addressed to: Warren P. Mason, MD, Department of Medicine, Princess Margaret Hospital, 610 University Avenue, Suite 18-717, Toronto, Ontario, M5G 2M9, Canada; Ph: +1 416 946 2277; Fax: +1 416 946 2284; Email: Warren.Mason@uhn.on.ca.